Alerts

Pharmacists can substitute 10 mg simvastatin tablets during the shortage of the 5 mg tablets.

Vitality Brands Worldwide Pty Ltd is recalling three batches of Cancer Council Sunscreen Clear Zinc Kids SPF50+ 110g due to the potential for the product to become separated.

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues. This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

Pharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.

The safety information for denosumab products used to treat osteoporosis has been updated to strengthen the existing warning for multiple spinal fractures after discontinuation or delay of treatment.

Bondi Sands Pty Ltd is recalling five batches of sunscreen due to the potential for the lotions to become separated.

Product correction: Ypsomed Australia is reminding users to ensure they use a compatible smart device and operating system (OS) when using the Mylife CamAPS FX app.

We have extended the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Labetalol) Instrument 2025 (SSSI) to 31 December 2025.

Phytologic Holdings Pty Ltd is recalling one batch of Henry Blooms Infant Liquid D3 & K2 with Probiotic due to a dosing syringe error.

We are aware of the recent report of a death of a child overseas. The death has been found to have been caused by a fire that occurred during the use of a hyperbaric chamber device.

We have investigated 2 serious adverse event cases in young babies who had EMLA (prilocaine/lidocaine cream) applied to their skin for local anaesthesia. Both cases were likely to have involved overdose.

TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.

We are issuing a safety advisory regarding imported unregistered melatonin products following testing by TGA Laboratories.

Our investigation into concerns about Vyvanse’s potential lack of effectiveness, quality and safety found no issues of concern.

Consumers are advised that several sunscreen products are being recalled by sponsors. This follows preliminary testing evidence indicating that the SPF levels of their products may be lower than what is claimed on their labels.

We are issuing a safety advisory about the increasing importation and use of unregistered oral methylene blue (methylthioninium chloride) products in Australia.

Stryker is conducting a Critical Product Correction of Pad-Paks used with the HeartSine samaritan Public Access Defibrillator (PAD), with an expiry date range between 17 April 2025 to 01 August 2029.

Product correction and Product alert. This update includes new information regarding the software correction, actions for healthcare professionals and inclusion of the single chamber (SR) pacemaker.

We continue to receive reports of lead poisoning linked to imported or unregistered Ayurvedic medicines contaminated with heavy metals.

Pharmacists can dispense 200 mg tablets during the shortage.

Grace & Fire Pty Ltd (trading as Ultra Violette) is recalling all batches of Ultra Violette Lean Screen SPF 50+ due to inconsistency in the SPF level of the product.

Star Combo Australia Pty Ltd is recalling multiple batches of four Living Healthy High Strength Gummies products due to non-compliant labelling.

Product Alert: Australasian Medical & Scientific Ltd (AMSL), the sponsor of the t:slim X2 insulin pump, has identified that certain versions of the device have a wiring problem with the speaker.

Using a home-use foetal heart monitor to check a baby’s heartbeat may seem reassuring but it can be dangerously misleading. We have received reports of instances where they have provided false reassurance, leading to delayed medical attention and infant deaths.

Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules between 21 August and 31 December 2025.